Detection of biomarkers for alcoholism by two-dimensional differential gel electrophoresis

Alcoholism: Clinical and Experimental Research

Volumn 31, Issue SUPPL. 1, 2007, Pages

  Wu, Di ^a   Tomonaga, Takeshi ^a   Sogawa, Kazuyuki ^a   Satoh, Mamoru ^a   Sunaga, Masahiko ^a   Nezu, Masahiko ^a   Oh Ishi, Masamichi ^a   Kodera, Yoshio ^b   Maeda, Tadakazu ^b   Ochiai, Takenori ^a   Nomura, Fumio ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

2 D DIGE; Alcoholism; Biomarker

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; PLASMA PROTEIN; PROTEIN;

ABSTINENCE; ADULT; AGAR GEL ELECTROPHORESIS; AGED; ALCOHOLISM; CLINICAL ARTICLE; COMPUTER PROGRAM; CONFERENCE PAPER; DISEASE MARKER; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SERUM; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 33846317788     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2006.00289.x     Document Type: Conference Paper

References (21)

1. Ahmed N, Barker G, Oliva K, Garfin D, Talmadge K, Georgiou H, Quinn M, Rice G (2003) An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics 3:1980-1987.
2. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26:332-339.
3. Deitrich RA, Dunwiddie TV, Harris RA, Erwin VG (1989) Mechanism of action of ethanol: initial central nervous system actions. Pharmacol Rev 41:489-537.
4. Figeys D (2003) Proteomics in 2002: a year of technical development and wide-ranging applications. Anal Chem 75:2891-2905.
5. Gharbi S, Gaffney P, Yang A, Zvelebil MJ, Cramer R, Waterfield MD, Timms JF (2002) Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 1:91-98.
6. Lakshman R, Tsutsumi M, Ghosh P, Takase S, Anni H, Nikolaeva O, Israel V, Anton RF, Lesch OM, Helender A, Eriksson G, Jeppson JQ, Marmillot P, Rao MN (2001) Alcohol biomarkers: clinical significance and biochemical basis. Alcohol Clin Exp Res 25:67S-70S.
7. Lee JR, Baxter TM, Yamaguchi H, Wang TC, Goldenring JR, Anderson MG (2003) Differential protein analysis of spasomolytic polypeptide expressing metaplasia using laser capture microdissection and two-dimensional difference gel electrophoresis. Appl Immunohistochem Mol Morphol 11:188-193.
8. Lieber CS (2000) Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 32:113-128.
9. Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T, Nomura F, Matsubara H, Shimada H, Ochiai T (2005) Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 6:1011-1018.
10. Nomura F, Tomonaga T, Sogawa K, Ohashi T, Nezu M, Sunaga M, Kondo N, Iyo M, Shimada H, Ochiai T (2004) Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization-mass spectrometry. Proteomics 4:1187-1194.
11. Oh-Ishi M, Maeda T (2002) Separation techniques for high-molecularmass proteins. J Chromatogr B Analyt Technol Biomed Life Sci 771:49-66.
12. Oh-Ishi M, Satoh M, Maeda T (2000) Preparative two-dimensional gel electrophoresis with agarose gels in the first dimension for high molecular mass proteins. Electrophoresis 21:1653-1669.
13. Orrego H, Blake JE, Blendis LM, Kapur BM, Israel Y (1979) Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 2:1354-1356.
14. Poon TC, Johnson PJ (2001) Proteome analysis and its impact on the discovery of serological tumor markers. Clin Chim Acta 313:231-239.
15. Rosman AS, Lieber CS (1994) Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem 40:1641-1651.
16. Tomonaga T, Matsushita K, Yamaguchi S, Oh-Ishi M, Kodera Y, Maeda T, Shimada H, Ochiai T, Nomura F (2004) Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin Cancer Res 10:2007-2014.
17. Unlu M, Morgan ME, Minden JS (1997) Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18:2071-2077.
18. Van den Bergh G, Clerens S, Cnops L, Vandesande F, Arckens L (2003) Fluorescent two-dimensional difference gel electrophoresis and mass spectrometry identify age-related protein expression differences for the primary visual cortex of kitten and adult cat. J Neurochem 85:193-205.
19. Woong-Shick A, Sung-Pil P, Su-Mi B, Joon-Mo L, Sung-Eun N, Gye-Hyun N, Young-Lae C, Ho-Sun C, Heung-Jae J, Chong-Kook K, Young-Wan K, Byoung-Don H, Hyun-Sun J (2005) Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer. Cancer Sci 96:197-201.
20. Yan JX, Devenish AT, Wait R, Stone T, Lewis S, Fowler S (2002) Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics 2:1682-1698.
21. Zhou G, Li H, DeCamp D, Chen S, Shu H, Gong Y, Flaig M, Gillespie JW, Hu N, Taylor PR, Emmert-Buck MR, Liotta LA, Petricoin EF 3rd, Zhao Y (2002) 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 1:117-124.